Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v2-FR
Language English French
Date Updated 2022-02-01 2021-11-18
Drug Identification Number 02224801 02224801
Brand name RYTHMODAN RYTHMODAN
Common or Proper name Disopyramide Disopyramide
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH CHEPLAPHARM ARZNEIMITTEL GMBH
Ingredients DISOPYRAMIDE DISOPYRAMIDE
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size Blister Pack (84 Caps) Blister Pack (84 Caps)
ATC code C01BA C01BA
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-30 2021-11-18
Estimated end date 2022-02-28 2021-12-10
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments